Artis BioSolutions focuses on developing innovative biotechnologies aimed at addressing critical challenges in healthcare. Their primary technologies include advanced biomanufacturing processes that enhance the production of biologics, such as vaccines and therapeutic proteins. By leveraging proprietary methods, Artis aims to improve the efficiency, scalability, and cost-effectiveness of biopharmaceutical production, ultimately leading to more accessible treatments for patients.

In addition to biomanufacturing, Artis BioSolutions is engaged in the development of novel delivery systems that enhance the efficacy of therapeutic agents. These systems are designed to optimize the targeting and release of drugs, ensuring that they reach their intended sites of action more effectively. The company’s commitment to scientific research and innovation positions it at the forefront of biotechnology, with a focus on improving patient outcomes through cutting-edge solutions.

Artis BioSolutions mission is to advance genetic medicines and biologics from early development to market. Designed to support breakthrough treatments, we offer innovative technology, deep expertise, and a client-focused approach to streamline processes, improve efficiency, and scale across various therapeutic areas. Backed by Oak HC/FT, a leading venture and growth equity firm, we empower biopharma companies to bring life-changing therapies to patients faster.

Artis BioSolutions

Company Details